Corporate calendar for Krystal Biotech, Inc. (KRYS): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Krystal Biotech, Inc. is a clinical-stage biotechnology company focused on developing redosable gene therapies to address severe orphan diseases across the United States. Its most advanced therapeutic candidate, beremagene geperpavec (B-VEC), is currently undergoing Phase III clinical evaluation for the treatment of dystrophic epidermolysis bullosa.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | $1.03 | $19.67B |
| 2026-09-15 | $0.05 | $88M |
| 2026-09-15 | $0.15 | $1.04B |
| 2026-09-15 | $24M |
Price
| Price | $337.83 |
| Market Cap | $10.0B |
| Exchange | NASDAQ |
| Country | US |
Related companies: ACLX · ALKS · ARWR · CRSP · MTSR · PCVX · PTCT
Explore sector: Healthcare · Biotechnology
More sections of KRYS: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks